As healthcare systems and private hospital groups worldwide seek to expand robotic-assisted minimally invasive surgery (RAMIS) while managing escalating capital and consumable costs, China's surgical robotics sector has emerged as a formidable global force. At the vanguard of this movement is the Toumai® Four-Arm Laparoscopic Surgical Robot, engineered and manufactured in Shanghai by MicroPort MedBot. With full domestic NMPA clearance and European Union CE MDR certification, Toumai® delivers da Vinci-caliber surgical dexterity and visualization at a fraction of the total cost of ownership.
For international hospital directors, surgical department chairs, and medical device distributors looking to evaluate and procure China's premier surgical robotic platform, China Medical Concierge – Shanghai (CMCS) serves as your trusted on-ground procurement liaison and clinical navigation partner.
1. Core Clinical Scenarios & Real-World Surgical Applications
The Toumai® system features an open-console ergonomic master station, a four-arm patient cart with 7-degree-of-freedom wristed instruments, and a high-definition 3D stereoscopic vision system. It is clinically utilized across multi-quadrant, high-complexity procedures:
Urological Oncology & Reconstruction
- Robot-Assisted Radical Prostatectomy (RARP): Millimeter-level dissection within the narrow male pelvis, maximizing autonomic neurovascular bundle preservation to safeguard postoperative erectile function and urinary continence.
- Nephron-Sparing Partial Nephrectomy: Precise tumor enucleation and dual-layer renal parenchymal reconstruction under minimal warm ischemia time, vital for complex hilar or endophytic renal tumors.
- Radical Cystectomy with Intracorporeal Neobladder: Complete laparoscopic bladder resection with intracorporeal orthotopic ileal bladder reconstruction.
Gastrointestinal & Colorectal Surgery
- Ultra-Low Rectal Cancer Resection (TME): Total Mesorectal Excision in narrow pelvic anatomies, achieving clear circumferential margins while sparing pelvic nerve plexuses to ensure sphincter preservation.
- Radical Gastrectomy with D2 Lymphadenectomy: Systematic lymph node dissection along the celiac trunk, splenic vessels, and hepatic artery with fine vessel skeletonization.
Thoracic & Gynecological Oncology
- Mediastinal Tumor Resection & Thymectomy: Precise dissection around the phrenic nerves, superior vena cava, and innominate veins.
- Radical Hysterectomy with Pelvic Lymphadenectomy: Nerve-sparing radical surgery for early-stage cervical and endometrial malignancies.
5G Ultra-Remote Telesurgery
Toumai® has validated its low-latency control architecture across numerous trans-regional and transcontinental 5G telesurgical procedures spanning distances over 5,000 km, proving its hardware stability in remote and multi-center operating environments.
2. Leading Shanghai Hospitals & Surgical Teams Utilizing Toumai®
Toumai® is not merely a conceptual platform; it is actively installed and routine in China's top academic medical centers, backed by world-class surgical volume and rigorous clinical validation:
-
Shanghai Renji Hospital (Shanghai Jiao Tong University School of Medicine)
Department of Urology: Renji Urology is a National Key Specialty and one of Asia's highest-volume robotic surgery centers. Led by prominent urological oncology teams (including Prof. Xue Wei and fellow senior faculty), the department has performed extensive robot-assisted radical prostatectomies and partial nephrectomies with Toumai®, documenting equivalence in surgical margins, console time, and functional recovery compared to imported systems. -
Shanghai Ruijin Hospital (Shanghai Jiao Tong University School of Medicine)
Department of General Surgery / Minimally Invasive Surgery Center: Ruijin is renowned internationally as a pioneering cradle of laparoscopic and robotic surgery in China. Its gastrointestinal and hepatobiliary surgical teams utilize robotic platforms to treat complex abdominal malignancies, offering hands-on clinical data and standardized surgical pathway benchmarks. -
Shanghai Changhai Hospital (Naval Medical University)
Department of Urology: Home to the National Center for Urological Diseases and renowned pioneers in prostate cancer treatment, Changhai has integrated Toumai® in complex resections and multicenter comparative clinical trials.
3. Procurement Advantages for Overseas Buyers
International buyers selecting Toumai® gain distinct strategic and economic advantages:
- Unmatched Cost Efficiency: Capital investment is approximately 50% lower than traditional Western robotic platforms, with per-procedure consumable and maintenance costs reduced by up to 60%, drastically shortening the break-even period for private clinics and public hospitals alike.
- Robust Consumable Supply Chain: Manufactured within Shanghai's advanced MedTech cluster (Zhangjiang / Lingang), ensuring dependable production capacity, rapid dispatch of wristed instruments, and resilient supply lines.
- International Regulatory Authorizations: Approved under China NMPA (innovative green channel), European Union CE MDR, and Brazil ANVISA, with active regulatory submissions across Latin America, Southeast Asia, and the Middle East.
- Full Ecosystem Bundling: Available as a complete turnkey package comprising the master console, patient cart, vision cart, high-definition 3D camera system, reusable wristed instruments, and customized surgical simulator software.
4. How CMCS Assists Overseas Buyers with End-to-End Procurement
Procuring capital-intensive, Class III medical equipment from China requires rigorous local due diligence, clinical validation, regulatory navigation, and direct access to original manufacturers. CMCS provides an authoritative bridge:
- Clinical Site Visits & Live Surgical Observation: We arrange for overseas hospital executives, chief medical officers, and lead surgeons to visit top Shanghai teaching hospitals (e.g., Renji, Ruijin) to observe Toumai® operating in live complex surgical scenarios alongside top Chinese master surgeons.
- Factory Audits & Factory Acceptance Testing (FAT): CMCS coordinates on-site technical inspections and quality audits at MicroPort MedBot’s state-of-the-art Shanghai manufacturing campus, inspecting GMP cleanrooms, calibration rigs, and robotic testing lines.
- Direct Manufacturer Negotiation: As an independent local healthcare concierge and advisory, CMCS connects your procurement committee directly with manufacturer executive leadership and authorized export divisions, avoiding middlemen to secure preferential pricing, comprehensive warranty terms, and custom consumable supply contracts.
- Export Logistics, Cold-Chain & Installation Navigation: We coordinate with licensed bonded logistics partners in the Shanghai Free Trade Zone (Lingang/Waigaoqiao) for precision packaging, temperature-controlled transit, export customs clearance, and overseas engineer installation and training setups.
Compliance & Regulatory Advisory
China Medical Concierge – Shanghai (CMCS) is an independent healthcare management and medical procurement navigation consultancy based in Shanghai. CMCS is not a medical device manufacturer or direct distributor, nor a hospital. We facilitate on-ground technical navigation, clinical site inspections, factory audits, and direct supplier liaisons. All commercial supply contracts, warranties, and technical maintenance agreements are executed directly between the purchaser and the certified original equipment manufacturer (OEM) or its licensed export trade partners in compliance with international trade laws.
Initiate a Procurement Consultation or Hospital Visit
To schedule an on-ground factory inspection in Shanghai, organize a clinical observation at a partner hospital, or receive technical specifications and procurement packages for the Toumai® Surgical Robot, please contact our international liaison office:
- Email: contract@medicalsh.com
- WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
- Website: www.medicalsh.com
0件のコメント